Ashland Inc. (ASH)
NYSE: ASH · Real-Time Price · USD
67.82
+1.44 (2.17%)
Jul 28, 2026, 10:53 AM EDT - Market open
Ashland Financials Overview
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Revenue Revenue Growth | 1,808 | 1,824 | 2,113 | 2,191 | 2,391 | 2,111 |
Revenue Growth | -7.28% | -13.68% | -3.56% | -8.37% | 13.26% | 4.71% |
Gross Profit Gross Profit Growth | 543 | 549 | 618 | 668 | 830 | 670 |
Operating Income Operating Income Growth | 39 | -775 | -26 | 172 | 333 | 192 |
Net Income Net Income Growth | -706 | -845 | 169 | 178 | 927 | 220 |
Earnings Per Share EPS Growth | -14.91 | -18.23 | 3.36 | 3.31 | 3.20 | 2.82 |
EPS Growth | - | - | 1.51% | 3.44% | 13.48% | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Life Sciences Life Sciences Growth | 646 | 641 | 810 | 869 | 815 | 737 |
Personal Care Personal Care Growth | 571 | 577 | 634 | 598 | 678 | 592 |
Specialty Additives Specialty Additives Growth | 498 | 511 | 572 | 600 | 719 | 655 |
Intermediates Intermediates Growth | 132 | 137 | 144 | 185 | 256 | 178 |
Eliminations Eliminations Growth | -38 | -42 | -47 | -61 | -77 | -51 |
Revenue (Total) Revenue (Total) Growth | 1,808 | 1,824 | 2,113 | 2,191 | 2,391 | 2,111 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Cash & Investments Cash & Investments Growth | 343 | 215 | 300 | 417 | 646 | 210 |
Total Debt Total Debt Growth | 1,478 | 1,490 | 1,468 | 1,458 | 1,383 | 2,103 |
Net Cash (Debt) Net Cash Growth | -1,135 | -1,275 | -1,168 | -1,041 | -737 | -1,893 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -24.67 | -27.72 | -23.36 | -19.28 | -13.16 | -31.03 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 283 | 94 | 411 | 243 | -213 | 560 |
Capital Expenditures CapEx Growth | -85 | -98 | -137 | -170 | -113 | -105 |
Free Cash Flow Free Cash Flow Growth | 198 | -4 | 274 | 73 | -326 | 455 |
Free Cash Flow Growth | 500.00% | - | 275.34% | - | - | 550.00% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Gross Margin | 30.03% | 30.10% | 29.25% | 30.49% | 34.71% | 31.74% |
Operating Margin | 2.16% | -42.49% | -1.23% | 7.85% | 13.93% | 9.10% |
Pretax Margin | -35.07% | -44.35% | -1.14% | 7.30% | 8.62% | 6.40% |
Profit Margin | -37.89% | -45.07% | 9.42% | 7.67% | 7.57% | 8.20% |
FCF Margin | 10.95% | -0.22% | 12.97% | 3.33% | -13.63% | 21.55% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 28, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Dividend Per Share Dividend Per Share Growth | 1.660 | 1.640 | 1.580 | 1.440 | 1.270 | 1.150 |
Dividend Per Share Growth | 2.15% | 3.80% | 9.72% | 13.39% | 10.44% | 4.54% |
Dividend Yield | 2.50% | 3.45% | 1.83% | 1.76% | 1.34% | 1.31% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 28, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
PE Ratio | - | - | 25.88 | 24.68 | 29.68 | 31.60 |
Forward PE | 17.71 | 11.06 | 16.40 | 16.03 | 16.41 | 17.18 |
P/FCF Ratio | 15.54 | - | 14.92 | 57.06 | - | 11.16 |
PS Ratio | 1.70 | 1.20 | 1.93 | 1.90 | 2.14 | 2.41 |